A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1997
12/04/1997	CA2256310A1 Melanoma and prostate cancer specific antibodies for immunodetection and immunotherapy
12/04/1997	CA2255941A1 Prevention of graft-versus-host disease with t-cells including polynucleotides encoding negative selective markers
12/04/1997	CA2254983A1 Concentrated antibody preparation
12/04/1997	CA2254828A1 Identification of pyrazinamide-resistant mycobacteria and methods for treating mycobacterial infections
12/04/1997	CA2253818A1 Mammalian tolloid-like gene and protein
12/04/1997	CA2253410A1 New improved formulation for treatment of thromboembolism
12/03/1997	EP0810285A2 Mutants of human Interleukin-3
12/03/1997	EP0810209A2 Alpha - and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
12/03/1997	EP0810208A2 N-substituted Hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors
12/03/1997	EP0809996A2 Interferon conjugates
12/03/1997	EP0809708A1 Potentiators of antibacterial agents
12/03/1997	EP0809705A1 Nucleic acid-containing composition, preparation and use thereof
12/03/1997	EP0809701A1 Calcineurin regulatable adenylate cyclase
12/03/1997	EP0809700A1 Papilloma virus-like particles, fusion proteins and process for producing the same
12/03/1997	EP0809699A1 New chemokines expressed in pancreas
12/03/1997	EP0809698A1 NUCLEOTIDE AND DEDUCED AMINO ACID SEQUENCES OF TUMOR GENE Int6
12/03/1997	EP0809697A2 Human peroxisome proliferator activated receptors gamma
12/03/1997	EP0809695A1 Transcription factor - e2f-5
12/03/1997	EP0809692A1 Materials and methods relating to the regulation of polypeptide production in cells
12/03/1997	EP0809656A1 MONOCLONAL ANTIBODY SPECIFIC FOR $g(b)A4 PEPTIDE
12/03/1997	EP0809655A1 PEPTIDES AND PEPTIDOMIMETICS WITH STRUCTURAL SIMILARITY TO HUMAN p53 THAT ACTIVATE p53 FUNCTION
12/03/1997	EP0809654A1 Calcitonin salmon analogues, their preparation, medicinal use and use as analytical agents
12/03/1997	EP0809651A1 Thrombin inhibitors
12/03/1997	EP0809650A1 Serine protease inhibitors
12/03/1997	EP0809648A1 Neuropeptide y receptor
12/03/1997	EP0809517A1 Anti-transforming growth factor-beta gene therapy
12/03/1997	EP0809512A1 Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin
12/03/1997	EP0809511A1 Inhibition of angiogenesis using interleukin-12
12/03/1997	EP0809510A1 LYMPHOTOXIN-$g(a)/$g(b) COMPLEXES AND ANTI-LYMPHOTOXIN-BETA RECEPTOR ANTIBODIES AS ANTI-TUMOR AGENTS
12/03/1997	EP0809508A1 Anti-obesity proteins
12/03/1997	EP0809507A1 Novel highly potent agonists of growth hormone releasing hormone
12/03/1997	EP0809490A1 Use of lck sh2 specific compounds to treat autoimmune diseases and allograft rejection
12/03/1997	EP0809489A1 Medicament form for the delivery of collagenase to wounds and process for the preparation thereof
12/03/1997	EP0746343A4 METHODS AND COMPOSITIONS OF A BIOARTIFICIAL KIDNEY SUITABLE FOR USE -i(IN VIVO) OR -i(EX VIVO)
12/03/1997	EP0730651A4 Surface loop structural analogues of fibroblast growth factors
12/03/1997	EP0719286B1 Dextran esters, process for producing them and their use for encasing and encapsulating medicaments
12/03/1997	EP0689448B1 Angiogenine, and/or alpha1-microglobuline and/or complementary factor d for limiting protein secretion
12/03/1997	EP0590055B1 M-protein peptides of influenza virus as antiviral agents
12/03/1997	CN1166858A The tagA gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma
12/03/1997	CN1166838A Antibodies against allogenic and Xenogenic proteins, their use in diagnosis and therapy and methods for determination thereof
12/03/1997	CN1166786A Retroviral protease inhibitor combinations
12/03/1997	CN1166490A Prep of novel mercaptoacetylamide derivatives
12/03/1997	CN1166360A Compound zinc protein
12/03/1997	CN1166316A Combination therapy to treat osteoporosis
12/03/1997	CN1036590C Process for preparation of mercaptoacetylamide derivatives
12/02/1997	US5693858 Organic salts of N,N'-diacetyl cystine
12/02/1997	US5693815 Peptides
12/02/1997	US5693780 Recombinant antibodies for human therapy
12/02/1997	US5693779 Isolated polynucleotide encoding protein useful for treating or preventing syndromes involving inappropriate tissue proliferation
12/02/1997	US5693776 Nucleic acids specific for Rochalimaea quintana
12/02/1997	US5693775 Fibroblast growth factor homologous factor-1 (FHF-1) and methods of use
12/02/1997	US5693773 Capable of hybridizing to and inhibiting expression of nucleic acids having mixed purine/pyrimidine sequences by triplex formation; comprises three regions-duplex forming region, triplex forming region and linker region
12/02/1997	US5693764 Nucleotide or nucleoside photoaffinity compound modified antibodies, methods for their manufacture and use thereof as diagnostics and therapeutics
12/02/1997	US5693763 Antibodies to human carcinoma antigen
12/02/1997	US5693762 Humanized immunoglobulins
12/02/1997	US5693761 Genetic engineering; complementarity zones
12/02/1997	US5693760 Specific amino acid sequence consisting of position 2-135 includes a glycosylation site within position 96-98, binds beta-glalactoside containing moieties independent of absence of presence of calcium ions, stimulates hemagglutination
12/02/1997	US5693759 Human T-cell leukemia virus transcription modulators and screening assays
12/02/1997	US5693758 Polypeptide competitor specific for immunoglobulin e low affinity receptor sites
12/02/1997	US5693757 Huntingtin DNA, protein and uses thereof
12/02/1997	US5693755 Construction and expression of synthetic genes encoding envelopes of human T cell leukemia virus type I
12/02/1997	US5693754 Inhibitory binding protein for insulin-like growth factors
12/02/1997	US5693753 Method of isolating βA4 peptide species ending at carboxy-terminals residue 42 using monoclonal antibody 369.2B
12/02/1997	US5693752 Hexapeptides of specified amino acid sequences
12/02/1997	US5693750 Microbiocidal action against pneumocystis infections
12/02/1997	US5693671 Isomer is administered orally
12/02/1997	US5693670 Composition containing a dihydroxyacetone precursor
12/02/1997	US5693664 Use of R-(+)-α-lipoic acid, R-(-)dihydrolipoic acid and metabolites in the form of the free acid or salts or esters or amides for the preparation of drugs for the treatment of diabetes mellitus as well as of its sequelae
12/02/1997	US5693633 Angiotensin II antagonists
12/02/1997	US5693617 Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
12/02/1997	US5693616 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
12/02/1997	US5693615 Therapeutic compositions for osteoinduction
12/02/1997	US5693614 Drug for the treatment of senile dementia of the ischemic and hypoglycemic types
12/02/1997	US5693612 Used for prophylaxis and treatment of disorders of the circulation, bones and in tumor therapy, and as antimicrobial and antiviral active compounds
12/02/1997	US5693611 Cyclic peptide antifungal agents
12/02/1997	US5693610 Binding agent for growth factor
12/02/1997	US5693609 Antidiabetic agents; extended duration of action
12/02/1997	US5693608 Method of administering a biologically active substance
12/02/1997	US5693607 Administering to treat fibroproliferative disorders
12/02/1997	US5693535 Enzymatic nucleic acid molecule which specifically cleaves rna sequence
12/02/1997	US5693534 Enhancement of fertilization capability of oocytes
12/02/1997	US5693532 Respiratory syncytial virus ribozymes
12/02/1997	US5693530 Recombinant vectors; vaccines
12/02/1997	US5693502 Nucleic acid ligand inhibitors to DNA polymerases
12/02/1997	US5693499 Plasmid comprising promoter dna, dna coding signal peptide, dna coding coagulation factor viii amino acid sequences, and termination codon; gene expression
12/02/1997	US5693498 DNA encoding a plerocerciod growth factor
12/02/1997	US5693496 DNA encoding the mouse and human PH30 beta chain protein
12/02/1997	US5693495 Allergens of alder pollen and applications thereof
12/02/1997	US5693493 Modular assembly of antibody genes, antibodies prepared thereby and use
12/02/1997	US5693492 Purified dna molecule encoding drosophila avermectin and/or glutamate binding protein which functions as glutamate-gated anion channel
12/02/1997	US5693488 Transmembrane tyrosine phosphatase, nucleic acids encoding the same, and methods of use thereof
12/02/1997	US5693486 Microbiocides against escherichia, listeria, candida; contact lens antiseptic
12/02/1997	US5693481 Identifying melanoma cells that produce protein inhibitor of cytokine activity by culturing said cells, assaying medium for protein inhibitor
12/02/1997	US5693479 Obtaining trophoblast sample from conceptus prior to uterine implantation of the conceptus, administering transforming growth factor to sample, evaluating production by the sample of trophoblast fibronectin
12/02/1997	US5693473 Linked breast and ovarian cancer susceptibility gene
12/02/1997	US5693472 Detecting dna of seq id no:1,2,3 or 4 by hybridization probing and/or nucleotide sequence amplification; testing samples of surface water or feces; vaccines
12/02/1997	US5693470 Determining predisposition to hereditary non-polyposis colorectal cancer by testing cell samples for a mutant gene which affects expression of a protein indicator
12/02/1997	US5693343 Mixing acetonitrile solutions of antigen-sucrose matrix and glycolide-lactide copolymer, then emulsification with an oil and centrifuging yields microspheres containing encapsulated antigen for orally administered vaccines
12/02/1997	US5693338 Delivery composition comprising active agent, diketopiperazine, enzyme inhibitor
12/02/1997	US5693336 Contains a phosphatidylcholine, cholesterol and dimyristoylphosphatidylglycerol

1 ... 2667 2668 2669 2670 2671 2672 2673 2674 2675 2676 2677 2678 2679 2680 2681 2682 2683 2684 2685 2686 2687 ... 3163